Work

Target Doses of Heart Failure Medical Therapy and Blood Pressure

Year: 2019

Type: article

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2018.11.011

Authors: Poghni A. Peri-Okonny, Xiaojuan Mi, Yevgeniy Khariton, Krishna K. Patel, Laine Thomas, Gregg C. Fonarow, Puza P. Sharma, Carol I. Duffy, Nancy M. Albert, Javed Butler, Adrian F. Hernandez, Kevin McCague, Fredonia B. Williams, Adam D. DeVore, J. Herbert Patterson, John A. Spertus

Institutions: University of Missouri–Kansas City, Duke University, University of California, Los Angeles, Novartis (United States), Cleveland Clinic, University of Mississippi, University of North Carolina at Chapel Hill, Saint Luke's Hospital

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Novartis Pharmaceuticals Corporation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences

Awards: G1422855837, G1677357094, G9000051705, Mississippi Center for Clinical and Translational Research

OpenAlex ID: W2913792930

FWCI: 9.445

Cites: 41

Cited by: 103

Related to: 10